A single destination for timely, editor-curated robotics news from around the world.
Ambitious Bio has launched Corpus, a detailed protein map of healthy human tissues, which reportedly enhances protein detection by 28% to 78% in 181 comparisons with existing studies. This advancement allows for the identification of 56% more proteins in shared tissues compared to the Human Protein Atlas, aiding drug developers in assessing potential safety risks related to disease-targeted proteins. The significance of Corpus lies in its potential to fill the data gap in human biology, which is crucial for the advancement of biological AI. As AI technology evolves, the demand for comprehensive biological data becomes increasingly vital for developing effective medical interventions. Ambitious Bio aims to lead in this space by systematically generating reliable biological measurements. Looking ahead, the success of Corpus could pave the way for further innovations in biological AI, as the company continues to build the necessary infrastructure for data generation. No further timeline was disclosed at the time of publication.
AIInsider By Matt Swayne Sep 22, 2026 AI AI Funding & Investment AI FUNDING & INVESTMENT AI in Healthcare AI Startups BusinessRSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
Daily robotics news, in-depth analysis, conference highlights, and discussions with professionals worldwide.